These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 20593351

  • 1. Influence of intravenous iron therapy on novel markers of iron deficiency.
    Chinnappa S, Bhandari S.
    Int J Artif Organs; 2010 May; 33(5):297-301. PubMed ID: 20593351
    [Abstract] [Full Text] [Related]

  • 2. Usefulness of Reticulocyte Hemoglobin Equivalent in Management of Regular Hemodialysis Patients with Iron Deficiency Anemia.
    Dalimunthe NN, Lubis AR.
    Rom J Intern Med; 2016 May; 54(1):31-6. PubMed ID: 27141568
    [Abstract] [Full Text] [Related]

  • 3. Comparison of reticulocyte hemoglobin equivalent with traditional markers of iron and erythropoiesis in pediatric dialysis.
    Davidkova S, Prestidge TD, Reed PW, Kara T, Wong W, Prestidge C.
    Pediatr Nephrol; 2016 May; 31(5):819-26. PubMed ID: 26667237
    [Abstract] [Full Text] [Related]

  • 4. Very low doses of direct intravenous iron in each session as maintenance therapy in hemodialysis patients.
    Deira J, González-Sanchidrián S, Polanco S, Cebrián C, Jiménez M, Marín J, Gómez-Martino JR, Fernández-Pereira L, Tabernero J.
    Ren Fail; 2016 Aug; 38(7):1076-81. PubMed ID: 27197731
    [Abstract] [Full Text] [Related]

  • 5. Iron supplementation in haemodialysis--practical clinical guidelines.
    Silva J, Andrade S, Ventura H, Santos JP, Colaço S, Oliveira C, Ponce P.
    Nephrol Dial Transplant; 1998 Oct; 13(10):2572-7. PubMed ID: 9794562
    [Abstract] [Full Text] [Related]

  • 6. Comparison of two iron gluconate treatment modalities in chronic hemodialysis patients: results of a randomized trial.
    Giordano A, Arrigo G, Lavarda F, Colasanti G, Petrini C.
    J Nephrol; 2005 Oct; 18(2):181-7. PubMed ID: 15931646
    [Abstract] [Full Text] [Related]

  • 7. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO.
    Mittman N, Sreedhara R, Mushnick R, Chattopadhyay J, Zelmanovic D, Vaseghi M, Avram MM.
    Am J Kidney Dis; 1997 Dec; 30(6):912-22. PubMed ID: 9398141
    [Abstract] [Full Text] [Related]

  • 8. Transferrin saturation versus reticulocyte hemoglobin content for iron deficiency in Japanese hemodialysis patients.
    Kaneko Y, Miyazaki S, Hirasawa Y, Gejyo F, Suzuki M.
    Kidney Int; 2003 Mar; 63(3):1086-93. PubMed ID: 12631092
    [Abstract] [Full Text] [Related]

  • 9. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
    Chen YC, Hung SC, Tarng DC.
    Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
    [Abstract] [Full Text] [Related]

  • 10. Monitoring iron status in end-stage renal disease patients on hemodialysis.
    Rafi A, Karkar A, Abdelrahman M.
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
    [Abstract] [Full Text] [Related]

  • 11. Clinical interpretation of reticulocyte hemoglobin content, RET-Y, in chronic hemodialysis patients.
    Ng HY, Chen HC, Pan LL, Tsai YC, Hsu KT, Liao SC, Chuang FR, Chen JB, Lee CT.
    Nephron Clin Pract; 2009 Mar; 111(4):c247-52. PubMed ID: 19293593
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Iron replacement in hemodialysis patients with a normal serum ferritin level].
    Riedel MK, Morgenstern T.
    Dtsch Med Wochenschr; 2004 Sep 03; 129(36):1849-53. PubMed ID: 15368155
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Iron isomaltoside 1000: a new intravenous iron for treating iron deficiency in chronic kidney disease.
    Wikström B, Bhandari S, Barany P, Kalra PA, Ladefoged S, Wilske J, Thomsen LL.
    J Nephrol; 2011 Sep 03; 24(5):589-96. PubMed ID: 21240875
    [Abstract] [Full Text] [Related]

  • 16. Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study.
    Coyne DW, Kapoian T, Suki W, Singh AK, Moran JE, Dahl NV, Rizkala AR, DRIVE Study Group.
    J Am Soc Nephrol; 2007 Mar 03; 18(3):975-84. PubMed ID: 17267740
    [Abstract] [Full Text] [Related]

  • 17. The Content of Reticulocyte Hemoglobin and Serum Concentration of the Soluble Transferrin Receptor for Diagnostics of Anemia in Chronically Hemodialyzed Patients.
    Kurzawa T, Owczarek A, Strzelczyk JK, Gołąbek K, Wiczkowski A.
    Adv Clin Exp Med; 2016 Mar 03; 25(3):425-31. PubMed ID: 27629729
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Assessing iron status: beyond serum ferritin and transferrin saturation.
    Wish JB.
    Clin J Am Soc Nephrol; 2006 Sep 03; 1 Suppl 1():S4-8. PubMed ID: 17699374
    [Abstract] [Full Text] [Related]

  • 20. [Comparison of intravenous ascorbic acid versus intravenous iron for functional iron deficiency in hemodialysis patients].
    Ogi M, Horiuchi T, Abe R, Wakabayashi M, Wakabayashi T.
    Nihon Jinzo Gakkai Shi; 2004 Sep 03; 46(8):804-9. PubMed ID: 15645737
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.